Bacil Pharma Reports Q2 FY27 Loss of Rs 7.22 Lakh Amid Operational Inactivity
Bacil Pharma Ltd 路 Financial Result 路 14 Oct 2026, 9:46 pm
Bacil Pharma Reports Q2 FY27 Loss of Rs 7.22 Lakh Amid Operational Inactivity Bacil Pharma reported nil revenue from operations for Q2 ended 30th Sep'26, relying entirely on other income of Rs 9.18 lakh (up 3.0% QoQ). Consolidated net loss widened to Rs 7.22 lakh versus a loss of Rs 1.61 lakh in Q1 ended 30th Jun'26, heavily impacted by deferred tax expenses of Rs 4.23 lakh and finance costs of Rs 6.24 lakh. Basic and diluted EPS stood at Rs 0.06. Total consolidated assets stood at Rs 3,081.30 lakh, supported by current borrowings of Rs 552.24 lakh.
Original exchange filing (PDF)
More announcements from Bacil Pharma Ltd
- Intimation regarding execution of Agreement by Wholly Owned Subsidiary of the Company 路 05 Nov 2026
- Outcome of Board Meeting held on 14th October, 2026 路 14 Oct 2026
- Intimation for resignation of Company Secretary 路 09 Oct 2026
- Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results .... 路 14 Oct 2026
- Scrutinizers Report for the Annual General Meeting of the Company for FY 2025-2026 路 24 Sept 2026
- Outcome/Proceeding of Annual General Meeting of the Company 路 23 Sept 2026
- Annual Report for the Financial Year 2025-2026 路 31 Aug 2026
- Notice of Annual General Meeting to be held on 23rd September, 2026 路 30 Aug 2026
